Skip to main content
Article
Pulse High-Dose Vorinostat Can Be Delivered with Rituximab, Ifosphamide, Carboplatin, and Etoposide In Patients with Relapsed Lymphoma: Final Results of a Phase I Trial.
Blood (2010)
  • Lihua E Budde, Fred Hutchinson Cancer Research Center
  • Andrei Shustov, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Ted Gooley, Fred Hutchinson Cancer Research Center
  • George Oliviera, University of Washington
  • Tara Chen, University of Washington
  • Michelle Zhang, University of Washington
  • Thomas A. Warr
  • Thomas Boyd, University of Texas MD Anderson Cancer Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K Gopal, University of Washington
Publication Date
November 19, 2010
Citation Information
Lihua E Budde, Andrei Shustov, John M. Pagel, Ted Gooley, et al.. "Pulse High-Dose Vorinostat Can Be Delivered with Rituximab, Ifosphamide, Carboplatin, and Etoposide In Patients with Relapsed Lymphoma: Final Results of a Phase I Trial." Blood Vol. 116 Iss. 21 (2010) p. 2790 - 2790
Available at: http://works.bepress.com/john-pagel/188/